June 27, 2024 Market News Announcement Information
The turnover of the Shanghai and Shenzhen stock markets today was 626.4 billion, a decrease of 17 billion from the previous trading day. At the close, the Shanghai Composite Index fell 0.9%, the Shenzhen Component Index fell 1.53%, and the ChiNext Index fell 1.59%.
The three major U.S. stock indexes collectively opened lower, with the Dow down 0.02%, the Nasdaq down 0.06%, and the S&P 500 down 0.05%.
| News |
| Bian Zhigang, deputy director of the China National Space Administration, said that in the future, China will develop Chang'e-7 and Chang'e-8 probes in lunar exploration, of which Chang'e-7 will carry out environmental and resource exploration in the lunar polar region, and Chang'e-8 will carry out technical verification of the local utilization of lunar resources. In the future, we will work with international counterparts to discuss the construction of an international lunar scientific research station and share the scientific and technological achievements of lunar exploration. |
| The mainland plans to launch Tianwen-2 around 2025 to carry out asteroid exploration missions; Around 2030, Tianwen-3 and Tianwen-4 will be launched to carry out Mars sample return missions and Jupiter system exploration missions, respectively. |
| The Ministry of Commerce has received the application materials submitted by the China Chamber of Commerce for Import and Export of Machinery and Electronic Products on behalf of the industry. |
| Continental recently initiated the establishment of an e-sports working group at the International Organization for Standardization (ISO). The establishment of the e-sports working group and the successful establishment of the proposal for international standards for e-sports have filled the gap in international standards in this field and will strongly promote the development of the global e-sports industry. |
| The rainfall in the middle and lower reaches of the Yangtze River is still continuing, and all localities are making all-out efforts to rescue and provide disaster relief |
| Maziar Mike Doustdar, head of international business at Novo Nordisk, said the company would limit the sales of its blockbuster weight loss drug Wegovy (trade name: Novo Nordisk) in China to avoid an influx of Chinese patients leading to an inadequate supply of drugs in other parts of the world. |
| The Swiss Ministry of Finance announced on June 27 that Switzerland and the United States signed a new Foreign Account Tax Compliance Act (FATCA) agreement on the same day, and the changes to the financial account data swap model are expected to apply from 2027. |
| INFORMATION reports that Open AI earns up to $1 billion in annual revenue from model access, which is already more than Microsoft's revenue from its equivalent business. |
| Increase and decrease in holdings, repurchases, etc |
| 603356 Valin Seiko: The second largest shareholder with 9.5% of the shares, Jiedeng Zero Carbon plans to increase its holdings of the company's shares in the form of centralized bidding and block trading within 90 trading days from June 28, with the number of additional shares not less than 10 million shares, and no more than 12 million shares, accounting for about 7.5%-9% of the company's total share capital. |
| 603990 Meditech: Mianyang Haoxiang, the controlling shareholder of the company, voluntarily promised that within 6 months from June 28, 2024, Mianyang Haoxiang will not reduce its directly held shares of the company through centralized bidding or block trading in the secondary market. During the above-mentioned commitment period, if the shares are increased due to the company's bonus shares, conversion to share capital, allotment of shares, etc., the aforesaid commitment not to reduce holdings will also be complied with. |
| 000034 Digital China: The company intends to repurchase shares through centralized bidding transactions for follow-up employee stock ownership plans and/or equity incentive plans. The total amount of funds repurchased shall not be less than 100 million yuan and not more than 200 million yuan, and the repurchase price shall not exceed 40 yuan per share. |
| 002141*ST Xianfeng: The company intends to repurchase shares with 30 million yuan to 60 million yuan for the implementation of equity incentives, and the repurchase price does not exceed 1.54 yuan per share. According to the upper and lower limits of the total repurchase funds and the upper limit of the repurchase price, the total number of repurchased shares is 19.48 million shares - 38.96 million shares. |
| 002495 Jialong shares: It is planned to use its own funds to repurchase part of the company's shares in a centralized bidding transaction for the implementation of the company's equity incentive or employee stock ownership plan. The repurchase of shares shall not be less than RMB 50 million and not more than RMB 100 million (both inclusive), and the price of the repurchased shares shall not exceed RMB 2.20 per share (including the principal number). |
| 300639 Kaipu Bio: It plans to use its own funds to repurchase part of the company's shares in a centralized bidding transaction, and the repurchased shares will be used to maintain the company's value and shareholders' rights. The repurchase amount shall not be less than RMB 30 million (inclusive) and not more than RMB 60 million (inclusive). According to the upper limit of the repurchase price and the upper and lower limits of the repurchase amount, the number of shares to be repurchased is expected to be 4,166,700 shares to 8,333,300 shares, accounting for 0.64% to 1.29% of the company's total issued share capital. |
| Individual stock announcements |
| 002665ST hanggao: As of June 27, 2024, the closing price of the company's shares has been below 1 yuan for 20 consecutive trading days. According to the regulations, if the closing price of the company's shares is lower than 1 yuan for 20 consecutive trading days, the company's shares will be terminated by the Shenzhen Stock Exchange. According to the regulations, if the company's shares are terminated due to the forced delisting of transactions, the company's shares will not enter the delisting period. As a result, trading in the Company's shares will be suspended from the market open on Friday, June 28, 2024. |
| 300199 Hanyu Pharmaceutical: On June 27, the company received confirmation from the U.S. Food and Drug Administration (FDA) that it had received the submitted Tirpatide Drug master file (DMF). DMF is a set of documents related to product production and quality control, and enterprises and their products that have obtained DMF registration numbers are easy to be prioritized by customers, which is conducive to enterprises looking for market opportunities and developing customers. Tirpatide is the company's GLP-1 peptide drug pipeline product with international layout. |
Reprinted, not as a securities recommendation or investment advice, is intended to provide more information, and the author does not guarantee the accuracy of its content
#谈谈股市的新动态##妙笔生花创作挑战##文章首发挑战赛##头条创作挑战赛##分享股市热点##每日股市日记分享##记录我的2024#